期刊文献+

核苷酸结合寡聚结构域受体1作为先天免疫识别受体在血管平滑肌细胞激活中的作用 被引量:3

Role of nucleotide binding oligomerization domain receptor 1 as a new innate immune recognition receptor in activation of vascular smooth muscle cells
下载PDF
导出
摘要 目的:核苷酸结合的寡聚结构域受体1是新近发现的先天免疫细胞内模式识别受体。实验通过观察细菌细胞壁粘肽对血管平滑肌中细胞内核苷酸结合的寡聚结构域受体1激活和表达的影响,探讨核苷酸结合的寡聚结构域受体1介导的先天免疫信号通路在血管平滑肌激活中的作用。方法:实验于2006-06/2007-03在大连医科大学附属二院中心实验室完成。①实验材料:人冠状动脉血管平滑肌细胞购自Cambrex公司。②实验过程:体外培养人冠状动脉血管平滑肌细胞,用核苷酸结合的寡聚结构域受体1激动剂细菌细胞壁粘肽(10mg/L)刺激0,3,6和24h。③实验评估:用实时定量反转录-聚合酶链反应检测平滑肌细胞中核苷酸结合的寡聚结构域受体1mRNA的表达,用酶联免疫吸附法检测细胞培养物上清液中白细胞介素8和肿瘤坏死因子α的浓度。结果:①血管平滑肌细胞在静息状态下表达低水平的核苷酸结合的寡聚结构域受体1。细菌细胞壁粘肽刺激能够引起血管平滑肌细胞中核苷酸结合的寡聚结构域受体1mRNA表达上调(从0.164±0.005增加到0.231±0.027,P<0.05)。②酶联免疫吸附法显示细胞培养物上清液中白细胞介素8和肿瘤坏死因子α的浓度也显著增加[白细胞介素8从(0.12±0.01)μg/L增加到(2.31±0.11)μg/L,肿瘤坏死因子α从(4.22±0.50)ng/L增加到(143.11±12.58)ng/L,P<0.01]。结论:推测血管平滑肌细胞中的核苷酸结合的寡聚结构域受体1介导的先天免疫信号通路被激活,参与了动脉粥样硬化的发生和发展。 AIM: Nucleotide binding oligomerization domain receptor 1 (NOD1) is a recently identified intracellular pathogen pattern recognition receptor of innate immunity. This study was designed to explore the role of NODl-mediated innate immune signal pathway in the activation of vascular smooth muscle cells (VSMCs), and investigate the effect of peptidoglycan (PGN) on the activation and expression of NOD1 in human VSMCs. METHODS: The experiment was performed in the central laboratory of the Second Affiliated Hospital of Dalian Medical University from June 2006 to March 2007.①Subject: Human coronary artery VSMCs were purchased from Cambrex company.② Methods: Human coronary artery VSMCs were cultured in vitro, and stimulated with NOD1 agonist PGN (10 mg/L) for 0, 3, 6 and 24 hours. ③ Evaluation: The mRNA expression of NOD1 in VSMCs was measured by real time quantitative reverse transcription-polymerase chain reaction. The concentration in the culture supernatants of interleukin-8 (IL-8) and tumor necrosis factor-α (TNF-α ) was determined by enzyme linked immunosorbent assay. RESULTS: ①Human VSMCs constitutively expressed a low level of NOD1 at resting condition. Upon PGN stimulation, the expression of NOD1 mRNA was up-regulated in VSMCs, from 0.164±0.005 to 0.231 ±0.027 (P 〈 0.05).②Enzyme linked immunosorbent assay showed the concentration in the culture supernatants of IL-8 and TNF-α increased significantly, IL-8 from (0.12±0.01) μg/L to (2.31 ±0.11) μg/L and TNF-α from (4.22±0.50) ng/L to (143.11 ± 12.58) ng/L, respectively (P 〈 0.01). CONCLUSION: The NODl-mediated innate immune pathway may be involved in the atherogenesis though the activation of VSMCs.
作者 丁彦春 曲鹏
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第11期2021-2024,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献20

  • 1Mulvihill ER, Jaeger J, Sengupta R, et al. Atherosclerofic plague smooth muscle cells have a distinct phenotype. Arterioscl Thromb Vasc Biol 2004, 24:1-7
  • 2Hansson GK.Inflammation,atherosclerosis and coronary artery disease.N Eng J Med 2005,352:1685-1695
  • 3Sirard JC,Vignal C,Dessein R, et al. Nod-like receptors: cytosolic watchdogs for immunity against pathogens.PloS Pathog 2007,3:1829-1836
  • 4Kanneganti TD,Lamkanfi M,Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007, 27:549-559
  • 5Kufer TA, Banks DJ,Philpott DJ.Innate immune sensing of microbes by Nod proteins. Ann N Y Acad Sci 2006, 1072:19-27
  • 6Yan ZQ,Hansson GK.Innate immunity, macrophage activation, and atherosclerosis.Immunol Rev 2007, 219:187-203
  • 7de Graaf R, Kloppenburg G, Kitslaar PJ, et al. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 2006, 8:1859-1865
  • 8马林,丁彦春,崔晓琼,姜华,王虹艳,曲鹏.Toll样受体4—核因子κB信号通路在血管成形术后再狭窄过程中的作用[J].中国动脉硬化杂志,2006,14(7):596-600. 被引量:6
  • 9Cao F, Castrillo A, Tontonoz P, et al. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 2007,75:753-759
  • 10Inohara,Chamaillard, McDonald C, et al. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005,74:355-383

二级参考文献11

  • 1Charles A,Janeway Jr,Medzhitov R.Innate immune recognition[J].Annu Rev Immunol,2002,20:197-216
  • 2Ginnpease ME,Whisler RL,Redox.Singnals and NF-κB activation in T cells[J].Free Radical,1998,25:346-361
  • 3Ialenti A,Inaaro A,Maffia P,Capasso F,Pinto A,Kareda Y,et al.Role of nuclear factor kappa B in a rat model of vascular injure[J].Naunyn Schmicdebergs Arch Pharmacol,2001,364 (4):343
  • 4Sasu S,LaVerda D,Qureshi N,David,Nilofer,Golenbock,et al.Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor4 and p44/p42 mitogen-activated protein kinase activation[J].Circ Res,2001,89:244-250
  • 5Saskia CG,Hollestelle,Magreet,Vries,Aryan H,Ben J,et al.Toll-like receptor 4 is involved in outward arterial remodeling[J].Circulation,2004,109:393-398
  • 6Okamura Y,Watari M,Jerud ES,Sally T,Ishizaka,Jeffrey Rose,et al.The extra domain A of fibronectin activates Toll-like receptor 4[J].J Biol Chem,2001,276:10 229-233
  • 7Eschert H,Pawlus E,Carnuccio R,D'Acquisto F,Maiello FM.Molecular effects of HMG-CoA reductase inhibitors on smooth muscle cell proliferation[J].J AM Coll Cardiol,2001,37:337
  • 8Monica,Qrtego,CarmenBustors,Miguel A,Heep A,Tempel K,et al.Atorvastatin in reduces NF-κB activation and chemokine expression in vascular smooth cells and mononuclear cells[J].Atherosclerosis,1999,147:253-261
  • 9Boekholdt SM,Agema WR,Peters RJ,Aeilko H,Emdst E,Pieter H,et al.Variants of toll-like receptor4 modify the efficacy of statin therapy and the risk of cardiovascular events[J].Circulation,2003,107:2 416-421
  • 10Topol EJ,Serruys PW,Iris Goldbergb,Gad Keren.Frontiers in interventional cardiology[J].Circulation,1998,98:1 802-820

共引文献5

同被引文献50

  • 1王虹艳,曲鹏,富晶,姜华.TLR4激动上调内皮细胞氧化低密度脂蛋白受体LOX-1表达[J].高血压杂志,2005,13(7):422-426. 被引量:10
  • 2王虹艳,曲鹏,吕申,刘敏,姜华.Toll样受体4/核因子κB和氧化低密度脂蛋白受体LOX-1对单核内皮细胞黏附的影响[J].中华心血管病杂志,2005,33(9):827-831. 被引量:15
  • 3马林,丁彦春,崔晓琼,姜华,王虹艳,曲鹏.Toll样受体4—核因子κB信号通路在血管成形术后再狭窄过程中的作用[J].中国动脉硬化杂志,2006,14(7):596-600. 被引量:6
  • 4Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity[ J]. Cell, 2006, 124(4) : 783-801.
  • 5Yah ZQ, Hansson GK. Innate immunity, macrophage acti- vation, and atherosclerosis[J]. Immunol Rev, 2007, 219(10): 187-203.
  • 6Michelsen KS, Doherty TM, Shah PK, et al. Role of Toll- like receptors in atherosclerosis [ J ]. Circ Res, 2004, 95 (12) : 96-97.
  • 7Methe H, Kim JO, Kofler S, et al. Expansion of circulat- ing Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome [ J ]. Circulation, 2005, 111 (20) : 2 654-661.
  • 8Chavez-Sanchez L, Madrid-Miller A, Chavez-Rueda K, et al. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and mono- cytes triggers the inflammatory response [ J ]. Hum Immu- nol, 2010, 71(8) : 737-744.
  • 9Grenier D, Grignon L. Response of human macrophage-like cells to stimulation by Fusobaeterium nucleatum ssp. nu- cleatum lipopolysaceharide [ J ]. Oral Microbiol lmmunol, 2006, 21(3): 190-196.
  • 10den Dekker WK, Cheng C, Pasterkamp G, et al. Toll like receptor 4 in atherosclerosis mad plaque destabilization [ J ]. Atherosclerosis, 2010, 209(2): 314-320.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部